Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-07 Sale | 2020-12-09 7:48 pm | Replimune Group Inc. | REPL | Dhingra Kapil Director | 40,000 | $45.56 | $1,822,395 | 3,169 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Option Award | 2024-04-17 4:15 pm | N/A 2034-04-14 | CARGO Therapeutics Inc. | CRGX | Dhingra Kapil Director | 49,265 | $0 | 49,265 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-05-16 Option Award | 2023-05-17 9:06 pm | N/A 2033-05-15 | Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 8:03 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 25,200 | $0 | 25,200 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 7:05 pm | N/A 2032-06-09 | Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:12 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-22 6:13 pm | N/A 2031-06-17 | Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:39 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Dhingra Kapil Director | 80,000 | $0 | 0 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:11 pm | N/A 2031-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-22 4:59 pm | N/A 2031-01-19 | Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director | 29,842 | $0 | 29,842 (Direct) | View |
Ownership | 2021-01-22 4:53 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director | 0 | $0 | 69,353 (Direct) | View |
| 2020-12-07 Exercise | 2020-12-09 7:48 pm | N/A N/A | Replimune Group Inc. | REPL | Dhingra Kapil Director | 40,000 | $1.75 | 3,169 (Direct) | View |
| 2020-12-07 Exercise | 2020-12-09 7:48 pm | N/A 2026-01-21 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 40,000 | $0 | 3,169 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-15 5:46 pm | N/A 2030-05-13 | FIVE PRIME THERAPEUTICS INC. | FPRX | Dhingra Kapil Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-02 4:31 pm | N/A 2030-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2019-06-10 Option Award | 2019-06-12 6:11 pm | N/A 2029-06-09 | FIVE PRIME THERAPEUTICS INC | FPRX | Dhingra Kapil Director | 15,000 | $0 | 15,000 (Direct) | View |